A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma.

Cancer Chemother Pharmacol · 2012 · PMC3265723 · PMID 21800112

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

borderline significantP = 0.055so close (0.05 < p ≤ 0.1)

A borderline significant correlation with improved response was noted in metastatic patients who received GTX as their first-line therapy (adjusted OR 2.56, 95% CI 0.62–10.59, P = 0.055).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.